CIK cells, primarily consisting of CD3+CD56+ T-cell subsets generated by stimulation with IFN-γ, IL-2, and anti-CD3 monoclonal antibodies, mediate tumor cell killing through both the perforin/granzyme B pathway and death receptor-mediated signaling such as Fas/FasL (50). Here, GZMB is linked to neoplasm.